Therapeutic Asset Ratings
251 results matching 1 filter
133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
FILGRASTIM
Neutropenia
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
P4
BBB
(76)
Lipitor
Atorvastatin
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
P4
BBB
(73)
Romiplostim
Thrombocytopenia
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
P3
BB
(70)
(+)-VINCRISTINE
Recurrent Marginal Zone Lymphoma
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
P3
BB
(70)
Lipitor
Advanced Renal Cell Carcinoma (RCC)
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
P3
BB
(69)
Carboplatin
Fallopian Tube Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
P3
BB
(68)
Lipitor
Advanced Cancers
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
P2/3
BB
(68)
Cyclophosphamide
HR+/HER2- Breast Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
P3
BB
(66)
Everolimus
HER2+ Breast Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
P3
BB
(66)
FLUOROURACILUM
Intestinal Neoplasms
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
P3
BB
(66)
Capecitabine
Brain Metastases
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
P3
BB
(65)
Capecitabine
Intestinal Neoplasms
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
P3
BB
(65)
Eloxatin
Intestinal Neoplasms
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
P3
BB
(65)
Docetaxel
HR Positive/HER2 Low Breast Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
P3
BB
(64)
Inno-206
HR Positive/HER2 Low Breast Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
P3
BB
(64)
(+)-VINCRISTINE
Marginal Zone Lymphoma
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
P3
BB
(64)
Cyclophosphamide
HR Positive/HER2 Low Breast Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
P3
B
(63)
Lipitor
Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
P3
B
(62)
Theprubicin
TACE
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
P3
B
(62)
Ethiodized Oil
TACE
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
P3
B
(61)
Famitinib
Extensive-stage Small-cell Lung Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
P2
B
(61)
S-1
Pancreatic Adenocarcinoma
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
P2/3
B
(61)
Axitinib
Advanced Solid Tumors
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
P3
B
(60)
Catequentinib
Whole-Brain Radiotherapy
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
P3
B
(60)
Ethiodized Oil
Immune Checkpoint Inhibitor
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
P3
B
(60)
Showing 1 to 25 of 251 assets
Previous
Page 1 of 11
Next